• How changing opioid prescribing patterns can impact risk scores

  By Christine M. Mytelka, Melanie K. Kuester, Colin R. Gray, Lucas Everheart | 19 April 2018

  This brief provides data on the decline in opioids prescribed to Medicaid expansion populations and the increased use of other non-opioid pain relief drugs.

• 2018 Corporate Pension Funding Study

  By Zorast Wadia, Alan H. Perry, Charles J. Clark | 18 April 2018

  During 2017, the private single-employer defined benefit plans of the Milliman 100 companies made significant funding improvements.

• Brexit: Beyond passporting: Implications for the UK insurance industry

  By Kyle Audley, Jennifer Strickland, Fred Vosvenieks | 18 April 2018

  This paper considers various future routes that the development of insurance regulation in the UK could take due to Brexit and the impact each of these might have on UK insurers.

• A “gold standard” for population health? Revisiting the FDA’s relationship with the Hippocratic Oath

  By Gillian Woollett, Bruce S. Pyenson | 16 April 2018

  The Food and Drug Administration should use a population health context to meet 21st century expectations for pharmaceutical risk.

• The exclusion of some nursing facility visits from MSSP assignment has potential unintended consequences

  By Tia Goss Sawhney, Kathryn V. Fitch, Cory Gusland | 16 April 2018

  This article describes the changes in the historical benchmarks and performance expenditures for a number of Medicare Shared Savings Program accountable care organizations and also explains the possible impact of these changes.

• Market commentary, 1st Quarter 2018

  13 April 2018

  Markets showed signs of volatility as investors feared an uptick in both global protectionism and inflation expectations.

• Borderland controls

  By Jennifer Strickland, Kyle Audley | 13 April 2018

  Brexit is likely to have a large impact on the insurance industry, and the approach taken towards Solvency II in particular will be a key determinant of the future of UK insurance regulation.

• Analysis of Dutch insurers’ Solvency and Financial Condition Reports in European context

  By Simon Cureton, Peter Franken, Judith Houtepen, Kamiel van Langen, Kendall Carolissen, Moussa M Ouédraogo | 12 April 2018

  This report provides a summary of the key solvency information of the main life and non-life insurance entities in the Netherlands based on the Solvency and Financial Condition Reports published in May 2017.

• Market Monitor UAE: Preliminary insurance disclosures, April 2018

  By Safder Jaffer, Asad Irshad | 11 April 2018

  The UAE insurance market enjoyed record profitability and strong premium growth in 2017.

• Milliman Market Monitor London - 29 March 2018

  By Neil Dissanayake, Peter Lin | 11 April 2018

  Equity markets experienced another volatile month, with the markets concerned about a potential trade war between the US and China.

See More Articles